1. Home
  2. JDZG vs RNAZ Comparison

JDZG vs RNAZ Comparison

Compare JDZG & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

JDZG

JIADE LIMITED

HOLD

Current Price

$1.19

Market Cap

7.6M

Sector

Real Estate

ML Signal

HOLD

Logo TransCode Therapeutics Inc.

RNAZ

TransCode Therapeutics Inc.

N/A

Current Price

$8.40

Market Cap

8.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JDZG
RNAZ
Founded
2020
2016
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.0M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
JDZG
RNAZ
Price
$1.19
$8.40
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
539.6K
4.5K
Earning Date
04-10-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.27
52 Week High
$4.06
$20.99

Technical Indicators

Market Signals
Indicator
JDZG
RNAZ
Relative Strength Index (RSI) 48.54 41.68
Support Level $1.14 $8.29
Resistance Level $2.26 $9.44
Average True Range (ATR) 0.17 0.52
MACD -0.05 -0.00
Stochastic Oscillator 9.92 21.49

Price Performance

Historical Comparison
JDZG
RNAZ

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

About RNAZ TransCode Therapeutics Inc.

TransCode Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing innovative drugs and diagnostics for treating and identifying cancer. TransCode recently commenced its first clinical trial. The Company's lead therapeutic candidate, TTX-MC138, comprises an oligonucleotide conjugated to an iron oxide nanoparticle designed to be administered by infusion to inhibit the ability of metastatic tumor cells to survive. The goal of the therapy, if approved, is to achieve durable disease regression and long-term patient survival.

Share on Social Networks: